Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Molecular and Biochemical Parasitology
|
June 1, 1990
Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase
H Döbeli, A Trzeciak, D Gillessen, et al.
The Journal of Experimental Medicine
|
September 19, 1979
Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody
J G Patrick Sissons, R D Schreiber, L H Perrin, et al.
Science (New York, N.Y.)
|
May 20, 1988
Aldolase activity of a Plasmodium falciparum protein with protective properties
U Certa, P Ghersa, H Döbeli, et al.
The Journal of Tropical Medicine and Hygiene
|
June 1, 1991
Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malaria
I K Srivastava, M Schmidt, M Grall, et al.
Molecular Biology & Medicine
|
December 1, 1988
Variation in p126, a parasitophorous vacuole antigen of Plasmodium falciparum
R L Coppel, P E Crewther, J G Culvenor, et al.
Antiviral Therapy
|
March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study
O T Rutschmann, M Opravil, A Iten, et al.
AIDS (London, England)
|
June 19, 1998
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study
O T Rutschmann, M Opravil, A Iten, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Molecular and Biochemical Parasitology
|
June 1, 1990
Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase
H Döbeli, A Trzeciak, D Gillessen, et al.
The Journal of Experimental Medicine
|
September 19, 1979
Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody
J G Patrick Sissons, R D Schreiber, L H Perrin, et al.
Science (New York, N.Y.)
|
May 20, 1988
Aldolase activity of a Plasmodium falciparum protein with protective properties
U Certa, P Ghersa, H Döbeli, et al.
The Journal of Tropical Medicine and Hygiene
|
June 1, 1991
Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malaria
I K Srivastava, M Schmidt, M Grall, et al.
Molecular Biology & Medicine
|
December 1, 1988
Variation in p126, a parasitophorous vacuole antigen of Plasmodium falciparum
R L Coppel, P E Crewther, J G Culvenor, et al.
Antiviral Therapy
|
March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study
O T Rutschmann, M Opravil, A Iten, et al.
AIDS (London, England)
|
June 19, 1998
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study
O T Rutschmann, M Opravil, A Iten, et al.
Page
of 9